16 February 2022

Clean Power Hydrogen Plc

("CPH2", the "Company" or the "Group")

Admission to Trading on AIM

and

First Day of Dealings

CPH2, the UK-based green hydrogen technology and manufacturing group that has developed the IP-protected Membrane-Free Electrolyser ("MFE"), is pleased to announce the admission of its entire issued ordinary share capital to trading on AIM ("AIM"), a market operated by the London Stock Exchange plc ("Admission").

CPH2 has been admitted to AIM and the commencement of trading of the Group's Ordinary Shares will become effective at 8:00a.m. under the ticker "CPH2". Admission follows an over-subscribed Placing by Cenkos Securities plc ("Cenkos") for a total of 67,717,818 Ordinary Shares at 45p per Ordinary Share (the "Placing Price"), raising gross proceeds of £30.5m (before expenses) (the "Placing").

Cenkos is acting as Nominated Adviser and sole broker in relation to the Admission.

Placing Statistics:

Jon Duffy, Chief Executive Officer of CPH2, said:

"Today's listing and over-subscribed placing, delivered in difficult stock market conditions, is an important milestone for CPH2 and will assist the rapid growth of the Group. The funds raised will further strengthen the Group's financial position and will enable CPH2 to build out our Doncaster manufacturing operation. CPH2 has an opportunity to penetrate an extremely fast-growing hydrogen market and aims to become a globally recognised, highly profitable designer, manufacturer and licensor of its MFE technology, targeting 4GW production capacity by 2030, an opportunity further advanced by the move onto the public markets.

"The Group is now in a position to continue significant investment into its research and development capacity and enhance our intellectual property position whilst establishing a stock of completed units to deliver the substantial and continually growing opportunity pipeline.

"I am delighted we have been awarded the London Stock Exchange's Green Economy Mark at Admission, which recognises companies that derive 50% or more of their total annual revenues from products and services that contribute to the global green economy.

"I am grateful for all the hard work of our team, and I would like to thank our new and existing shareholders for their support. We are confident in our ability deliver on the opportunities ahead and I look forward to providing updates on our progress as our business develops."

For more information, please contact:

Overview of CPH2

CPH2 is the holding company of Clean Power Hydrogen Group Limited ("Clean Power") which has almost a decade of dedicated research and product development experience. This experience has resulted in the creation of simple, safe and sustainable technology which is designed to deliver a modular solution to the hydrogen production market in a cost-effective, scalable, reliable and long-lasting manner. The Group's strategic objective is to deliver the lowest LCOH in the market in relation to the production of green hydrogen. The Group's MFE technology is already commercially available and demonstrating cost efficiencies and technological advantages.

In addition to a contracted orderbook of 4MW for delivery in 2022, the Group has an established pipeline of new opportunities at varying stages of development, including active discussions with current and quoted customers in respect of potential orders in excess of 160MW.

The Group designs and manufactures hydrogen production units that incorporate its MFE technology which, in combination with cryogenic gas separation, delivers hydrogen and oxygen in separate streams. When the Group's MFE is supplied by renewable electricity it delivers green hydrogen with a purity of up to 99.999% and medical grade oxygen.

Key Strengths

·      Flexible route to market - In addition to the Group being a developer and seller of the MFE technology through traditional product sales channels, the intellectual property protection obtained by the Group enables it to pursue international joint venture and licensing arrangements. Resultingly, the Group has the potential to offer a low-cost business model combined with the potential to scale in the short term.

·      Opportunity to penetrate a very fast-growing market - The development of the hydrogen economy is forecast to lead to a 650x increase in European demand for electrolysers by 2030, with an EU electrolysis capacity target equivalent to 40GW. This requires investment of up to c. €47bn towards electrolysers producing 10 million tonnes/year of renewable hydrogen. The Group aims to become a globally recognised and highly-profitable designer, manufacturer and licensor of its MFE technology and is targeting 4GW production capacity by 2030. Meeting this target would be equivalent to a 10 per cent. market share of the projected EU market, albeit the Group is aiming for traction with customers across the global marketplace, where required electrolyser capacity is estimated to reach 100GW within the same time frame.

·      High-calibre customer base - The Group has an existing blue-chip customer base and a contracted orderbook of 4MW of unit production for delivery in 2022, providing an excellent platform for future growth. Beyond this, the Group has an established pipeline of new opportunities at varying stages of development, including active discussions with current and quoted customers in respect of potential orders in excess of 160MW.

·      Acting as a disruptive fast follower - In a rapidly-developing market place, the Directors believe CPH2 is well placed to benefit from the favourable commercial and regulatory drivers as hydrogen becomes increasingly central to the delivery of global 'net zero' commitments.

·      Lowering the cost - The Group's product design underpins its ambition to offer end customers the lowest Levelised Cost of Hydrogen ("LCOH") on the green hydrogen market and to help establish hydrogen as a viable source of power in the future. When coupled with renewable electricity as a power source, the CPH2 electrolyser is capable of producing cheap, green hydrogen and medical grade oxygen.

CPH2's ISIN is GB00BP371R64 and its SEDOL is BP371R6.

To find out more, please visit: https://www.cph2.com

Notes to Editors

Clean Power Hydrogen plc ("CPH2") is a rapidly-growing UK-based green hydrogen technology and manufacturing group. The Group designs and manufactures hydrogen production units and is focused on the commercial production of green hydrogen in a simple, safe, and sustainable manner

CPH2 has advanced the development of hydrogen as a green energy by demonstrating a new form of production. CPH2 has developed unique, IP-protected Membrane-Free Electrolyser™ ("MFE") technology - an efficient, cost-effective and reliable means of producing hydrogen - which is disrupting the traditional electrolyser market and accelerating the progress towards a zero-carbon future.

CPH2 is listed on the AIM market of the London Stock Exchange ("LSE") (AIM: CPH2) and was awarded the Green Economy Mark by the LSE, which recognises listed companies that derive more than 50% of their revenues from the green economy.

Cenkos Securities plc, which is authorised and regulated by the Financial Conduct Authority in the UK, is acting exclusively for the Group and no one else in connection with Admission. Cenkos Securities plc will not regard any other person as its client in relation to Admission and will not be responsible to anyone other than the Group for providing the protections afforded to its clients, nor for providing advice in relation to the contents of this announcement or any transaction, arrangement or other matter referred to herein.